Skip Navigation and Go To Content
News from The University of Texas Health Science Center at Houston

Stories from The University of Texas Health Science Center at Houston (UTHealth Houston)

Navigation and Search

News Archive




Fernandez receives ASPPH Research Excellence Award

Maria E. Fernandez. PhD

December 20, 2021

 Maria E. Fernandez, PhD, the Lorne Bain Distinguished Professor in Public Health and Medicine, and professor of health promotion and behavioral science at UTHealth School of Public Health is the recipient of the 2022 Association of Schools and Programs of Public Health’s (ASPPH) Research Excellence Award. This distinguished award recognizes faculty who have devoted their careers to investigating public health issues. 


Study finds parental stress as a contributing factor linking maternal depression to child anxiety and depressive symptoms

Black and white image of a sad mother and child sitting on the floor.

December 1, 2021

A secondary analysis of the Fragile Families and Child Wellbeing Study (Fragile Families) found a bi-directional relationship where a mother’s mental health symptoms impacted the child’s mental health symptoms and vice versa, according to researchers with Cizik School of Nursing at The University of Texas Health Science Center at Houston (UTHealth Houston).



Remembering Tropical Storm Allison 20 years later: A lesson in resiliency

Tropical Storm Allison dropped more than 40 inches of rain on Houston in 2001, causing widespread flooding in the city and in the Texas Medical Center. (Photo by UTHealth)

June 8, 2021

In a region defined by hurricanes and severe weather, one storm stands out in its devastating impact on the Texas Medical Center and The University of Texas Health Science Center (UTHealth).

Tropical Storm Allison dropped more than 40 inches of rain on Houston in 2001, causing widespread flooding and severe consequences. McGovern Medical School at UTHealth and Memorial Hermann-Texas Medical Center were among the hardest-hit medical institutions.


Preclinical research reveals that new IgM antibodies administered intranasally to fight COVID-19 more potent than commonly used ones

Photo of Zhiqiang An, PhD, who was one of the lead authors  of a study that revealed engineered IgM antibodies were more potent than standard ones against COVID-19. (Photo by UTHealth)

June 3, 2021

A nasal therapy, built upon on the application of a new engineered IgM antibody therapy for COVID-19, was more effective than commonly used IgG antibodies at neutralizing the COVID-19 virus in animal models, according to research recently published by The University of Texas Health Science Center at Houston (UTHealth), The University of Texas Medical Branch at Galveston (UTMB Health), the University of Houston, and IGM Biosciences, Inc. 





Page 43 of 45


Search UTHealth News

Use the form below to perform a new search.